US · Healthcare · Healthcare Plans
EPS came in at 7.78 against a street estimate of 7.58 — a beat of 2.6%.
Analysts rate Cigna Corp a buy (19 buy, 6 hold, 0 sell out of 25) with an average price target of $339.36.
CONFIDENT Cigna beat Q2 expectations on strong specialty pharmacy growth and care coordination gains. Raised 2026 EPS guidance to $30.45+, signaling confidence despite moderating GLP-1 demand and PBM margin pressure from biosimilar adoption. Q2 2026 No geographic segment breakdown provided in call. Analysts pressed on PBM margin pressure (biosimilar/generic shift), Signature transition economics, and IDR/GLP-1 headwinds. Management emphasized net-positive Evernorth impact, confirmed Signature tracking to plan with 4% target margins, and called IDR abuses manageable but industry-wide waste worth $15B annually. 2026-07-30…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.55% |
| Vanguard Capital Management, LLC | 6.48% |
| State Street Corp | 4.65% |
| Dodge & Cox | 4.61% |
| Massachusetts Financial Services Company | 4.39% |
| FMR Inc | 4.15% |
| Sanders Capital, LLC | 3.84% |
| Geode Capital Management, LLC | 2.35% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 THE CIGNA GROUP – 10-Q SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Total Revenues (6M 2026): $140.2 billion vs. $132.7 billion (6M 2025) – | 2026-07-30 |
| Results announced · Q3 2026 THE CIGNA GROUP Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenues for Q2 2026: $71.7 billion, up 7% year-over-year from $67.2 billion in Q2 | 2026-07-30 |
| Reg FD disclosure · Q2 2026 THE CIGNA GROUP - FORM 8-K SUMMARY HEADLINE NUMBERS • Full year 2026 consolidated adjusted income from operations guidance: at least $30.35 per shar | 2026-05-13 |
| Quarterly report · Q1 2026 THE CIGNA GROUP - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenues: $68,494 million (Q1 2026) vs. $65,502 million (Q1 2025) — up 4.6% • Shareh | 2026-04-30 |
| Results announced · Q2 2026 THE CIGNA GROUP – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenues: $68.5 billion, up 5% vs Q1 2025 ($65.5 billion) • Shareholders' net in | 2026-04-30 |
| Shareholder vote results · Q2 2026 CIGNA GROUP (CI) – SHAREHOLDER MEETING SUMMARY HEADLINE NUMBERS • Annual Meeting held April 22, 2026 • 263,660,761 total shares outstanding and elig | 2026-04-27 |
| Proxy statement · Q2 2026 THE CIGNA GROUP PROXY STATEMENT SUMMARY FOR RETAIL INVESTORS --- CEO TOTAL COMPENSATION & CHANGE • 2025 CEO (David M. Cordani) total compensation: | 2026-03-13 |
| Annual report FY2025 THE CIGNA GROUP – 2025 FORM 10-K SUMMARY HEADLINE NUMBERS • Market capitalization: Approximately $88.0 billion as of June 30, 2025 • Outstanding sha | 2026-02-26 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $1.56 / share ex-date Sep 8, 2026 · pay Sep 23, 2026 | 2026-09-08 |
| Dividend | $1.56 / share ex-date Jun 4, 2026 · pay Jun 18, 2026 | 2026-06-04 |
| Dividend | $1.56 / share ex-date Mar 5, 2026 · pay Mar 19, 2026 | 2026-03-05 |
| Dividend | $1.51 / share ex-date Dec 4, 2025 · pay Dec 18, 2025 | 2025-12-04 |
| Dividend | $1.51 / share ex-date Sep 4, 2025 · pay Sep 18, 2025 | 2025-09-04 |
| Announcement | Date |
|---|---|
| 2026 outlook affirmed at least $30.35 adjusted income per share Cigna Group announced it will reaffirm its full year 2026 earnings guidance of at least $30.35 per share in adjusted income from operations during upcoming investor meetings. This is a confi | 2026-05-13 |
| Reaffirms full year 2026 adjusted income outlook of at least $30.25 per share Cigna Group reaffirmed its 2026 earnings guidance during an 8-K filing, stating it expects to confirm adjusted income from operations of at least $30.25 per share for full year 2026 during u | 2026-02-27 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cigna Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.